Copyright Reports & Markets. All rights reserved.

Global Transdermal Drug Patches Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Transdermal Drug Patches Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Nicotine Transdermal Patch
    • 1.3.3 Rivastigmine Transdermal Patch
    • 1.3.4 Fentanyl Transdermal Patch
    • 1.3.5 Others
  • 1.4 Market Analysis by Prescription Status
    • 1.4.1 Overview: Global Transdermal Drug Patches Consumption Value by Prescription Status: 2021 Versus 2025 Versus 2032
    • 1.4.2 Prescription Rx
    • 1.4.3 OTC
  • 1.5 Market Analysis by Patch Architecture
    • 1.5.1 Overview: Global Transdermal Drug Patches Consumption Value by Patch Architecture: 2021 Versus 2025 Versus 2032
    • 1.5.2 Drug-in-adhesive
    • 1.5.3 Matrix
    • 1.5.4 Reservoir
    • 1.5.5 Iontophoretic / active-assisted
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Transdermal Drug Patches Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospitals
    • 1.6.3 Retail
  • 1.7 Global Transdermal Drug Patches Market Size & Forecast
    • 1.7.1 Global Transdermal Drug Patches Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Transdermal Drug Patches Sales Quantity (2021-2032)
    • 1.7.3 Global Transdermal Drug Patches Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Hisamitsu Pharmaceutical
    • 2.1.1 Hisamitsu Pharmaceutical Details
    • 2.1.2 Hisamitsu Pharmaceutical Major Business
    • 2.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
    • 2.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Transdermal Drug Patches Product and Services
    • 2.2.4 Johnson & Johnson Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Johnson & Johnson Recent Developments/Updates
  • 2.3 Viatris
    • 2.3.1 Viatris Details
    • 2.3.2 Viatris Major Business
    • 2.3.3 Viatris Transdermal Drug Patches Product and Services
    • 2.3.4 Viatris Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Viatris Recent Developments/Updates
  • 2.4 UCB Pharma
    • 2.4.1 UCB Pharma Details
    • 2.4.2 UCB Pharma Major Business
    • 2.4.3 UCB Pharma Transdermal Drug Patches Product and Services
    • 2.4.4 UCB Pharma Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 UCB Pharma Recent Developments/Updates
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Transdermal Drug Patches Product and Services
    • 2.5.4 Novartis Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Novartis Recent Developments/Updates
  • 2.6 Teva Pharmaceutical
    • 2.6.1 Teva Pharmaceutical Details
    • 2.6.2 Teva Pharmaceutical Major Business
    • 2.6.3 Teva Pharmaceutical Transdermal Drug Patches Product and Services
    • 2.6.4 Teva Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Teva Pharmaceutical Recent Developments/Updates
  • 2.7 Nitto Denko
    • 2.7.1 Nitto Denko Details
    • 2.7.2 Nitto Denko Major Business
    • 2.7.3 Nitto Denko Transdermal Drug Patches Product and Services
    • 2.7.4 Nitto Denko Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Nitto Denko Recent Developments/Updates
  • 2.8 Grünenthal
    • 2.8.1 Grünenthal Details
    • 2.8.2 Grünenthal Major Business
    • 2.8.3 Grünenthal Transdermal Drug Patches Product and Services
    • 2.8.4 Grünenthal Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Grünenthal Recent Developments/Updates
  • 2.9 Mundipharma
    • 2.9.1 Mundipharma Details
    • 2.9.2 Mundipharma Major Business
    • 2.9.3 Mundipharma Transdermal Drug Patches Product and Services
    • 2.9.4 Mundipharma Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Mundipharma Recent Developments/Updates
  • 2.10 GSK
    • 2.10.1 GSK Details
    • 2.10.2 GSK Major Business
    • 2.10.3 GSK Transdermal Drug Patches Product and Services
    • 2.10.4 GSK Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 GSK Recent Developments/Updates
  • 2.11 Luye Pharma Group
    • 2.11.1 Luye Pharma Group Details
    • 2.11.2 Luye Pharma Group Major Business
    • 2.11.3 Luye Pharma Group Transdermal Drug Patches Product and Services
    • 2.11.4 Luye Pharma Group Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Luye Pharma Group Recent Developments/Updates
  • 2.12 Bayer
    • 2.12.1 Bayer Details
    • 2.12.2 Bayer Major Business
    • 2.12.3 Bayer Transdermal Drug Patches Product and Services
    • 2.12.4 Bayer Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Bayer Recent Developments/Updates

3 Competitive Environment: Transdermal Drug Patches by Manufacturer

  • 3.1 Global Transdermal Drug Patches Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Transdermal Drug Patches Revenue by Manufacturer (2021-2026)
  • 3.3 Global Transdermal Drug Patches Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Transdermal Drug Patches by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Transdermal Drug Patches Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Transdermal Drug Patches Manufacturer Market Share in 2025
  • 3.5 Transdermal Drug Patches Market: Overall Company Footprint Analysis
    • 3.5.1 Transdermal Drug Patches Market: Region Footprint
    • 3.5.2 Transdermal Drug Patches Market: Company Product Type Footprint
    • 3.5.3 Transdermal Drug Patches Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Transdermal Drug Patches Market Size by Region
    • 4.1.1 Global Transdermal Drug Patches Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Transdermal Drug Patches Consumption Value by Region (2021-2032)
    • 4.1.3 Global Transdermal Drug Patches Average Price by Region (2021-2032)
  • 4.2 North America Transdermal Drug Patches Consumption Value (2021-2032)
  • 4.3 Europe Transdermal Drug Patches Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Transdermal Drug Patches Consumption Value (2021-2032)
  • 4.5 South America Transdermal Drug Patches Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Transdermal Drug Patches Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Transdermal Drug Patches Sales Quantity by Type (2021-2032)
  • 5.2 Global Transdermal Drug Patches Consumption Value by Type (2021-2032)
  • 5.3 Global Transdermal Drug Patches Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Transdermal Drug Patches Sales Quantity by Application (2021-2032)
  • 6.2 Global Transdermal Drug Patches Consumption Value by Application (2021-2032)
  • 6.3 Global Transdermal Drug Patches Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Transdermal Drug Patches Sales Quantity by Type (2021-2032)
  • 7.2 North America Transdermal Drug Patches Sales Quantity by Application (2021-2032)
  • 7.3 North America Transdermal Drug Patches Market Size by Country
    • 7.3.1 North America Transdermal Drug Patches Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Transdermal Drug Patches Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Transdermal Drug Patches Sales Quantity by Type (2021-2032)
  • 8.2 Europe Transdermal Drug Patches Sales Quantity by Application (2021-2032)
  • 8.3 Europe Transdermal Drug Patches Market Size by Country
    • 8.3.1 Europe Transdermal Drug Patches Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Transdermal Drug Patches Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Transdermal Drug Patches Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Transdermal Drug Patches Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Transdermal Drug Patches Market Size by Region
    • 9.3.1 Asia-Pacific Transdermal Drug Patches Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Transdermal Drug Patches Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Transdermal Drug Patches Sales Quantity by Type (2021-2032)
  • 10.2 South America Transdermal Drug Patches Sales Quantity by Application (2021-2032)
  • 10.3 South America Transdermal Drug Patches Market Size by Country
    • 10.3.1 South America Transdermal Drug Patches Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Transdermal Drug Patches Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Transdermal Drug Patches Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Transdermal Drug Patches Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Transdermal Drug Patches Market Size by Country
    • 11.3.1 Middle East & Africa Transdermal Drug Patches Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Transdermal Drug Patches Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Transdermal Drug Patches Market Drivers
  • 12.2 Transdermal Drug Patches Market Restraints
  • 12.3 Transdermal Drug Patches Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Transdermal Drug Patches and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Transdermal Drug Patches
  • 13.3 Transdermal Drug Patches Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Transdermal Drug Patches Typical Distributors
  • 14.3 Transdermal Drug Patches Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Transdermal Drug Patches market size was valued at US$ 3622 million in 2025 and is forecast to a readjusted size of US$ 4193 million by 2032 with a CAGR of 2.2% during review period.
    Transdermal drug patches are adhesive pharmaceutical systems that deliver active ingredients across the skin into systemic circulation in a controlled manner, enabling sustained drug release, reduced dosing frequency, and improved adherence compared with many oral or injectable regimens. They are widely used in pain management, central nervous system disorders, hormone therapy, smoking cessation, cardiovascular disease, and selected specialty indications. In 2025, Global Transdermal Drug Patches sales are estimated at 1,600 million pieces, with an average ex-works price of 2.2 US$/piece.
    The main driver of the transdermal patch market is the combination of chronic disease management and adherence improvement. For diseases requiring stable plasma concentration or long-duration therapy, transdermal delivery offers differentiated value by reducing gastrointestinal burden, avoiding first-pass metabolism for selected molecules, and simplifying dosing schedules. In addition, companies continue to extend patch technology into CNS disorders, women's health, smoking cessation and pain therapy, while formulation and adhesion improvements are making patches more competitive for both branded and generic lifecycle management.
    This report is a detailed and comprehensive analysis for global Transdermal Drug Patches market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Transdermal Drug Patches market size and forecasts, in consumption value ($ Million), sales quantity (million Pieces), and average selling prices (US$/Piece), 2021-2032
    Global Transdermal Drug Patches market size and forecasts by region and country, in consumption value ($ Million), sales quantity (million Pieces), and average selling prices (US$/Piece), 2021-2032
    Global Transdermal Drug Patches market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (million Pieces), and average selling prices (US$/Piece), 2021-2032
    Global Transdermal Drug Patches market shares of main players, shipments in revenue ($ Million), sales quantity (million Pieces), and ASP (US$/Piece), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Transdermal Drug Patches
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Transdermal Drug Patches market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Viatris, UCB Pharma, Novartis, Teva Pharmaceutical, Nitto Denko, Grünenthal, Mundipharma, GSK, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Transdermal Drug Patches market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Nicotine Transdermal Patch
    Rivastigmine Transdermal Patch
    Fentanyl Transdermal Patch
    Others
    Market segment by Prescription Status
    Prescription Rx
    OTC
    Market segment by Patch Architecture
    Drug-in-adhesive
    Matrix
    Reservoir
    Iontophoretic / active-assisted
    Market segment by Application
    Hospitals
    Retail
    Major players covered
    Hisamitsu Pharmaceutical
    Johnson & Johnson
    Viatris
    UCB Pharma
    Novartis
    Teva Pharmaceutical
    Nitto Denko
    Grünenthal
    Mundipharma
    GSK
    Luye Pharma Group
    Bayer
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Transdermal Drug Patches product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Transdermal Drug Patches, with price, sales quantity, revenue, and global market share of Transdermal Drug Patches from 2021 to 2026.
    Chapter 3, the Transdermal Drug Patches competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Transdermal Drug Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Transdermal Drug Patches market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Transdermal Drug Patches.
    Chapter 14 and 15, to describe Transdermal Drug Patches sales channel, distributors, customers, research findings and conclusion.

    Buy now